订单暴涨200%、品牌合作激增11倍，京东买药秒送驶入增长快车道

Core Insights - The health consumption sector is undergoing significant generational changes, with a rapid increase in immediate, personalized, and scenario-based health demands, leading to the evolution of instant retail as a new infrastructure in the pharmaceutical and health industry [1] - The instant retail market is projected to exceed 2 trillion yuan by 2030, with the O2O pharmaceutical sector expected to be a major growth driver [1] Group 1: Business Growth and Strategies - JD's "Buy Medicine in Seconds" service has seen over 100% year-on-year growth in partnered stores and a 200% increase in order volume, with a network covering 490 cities [1] - The service's integration of platform traffic, refined operations, and digital capabilities has established a comprehensive empowerment system for pharmacies and pharmaceutical companies [1] - The platform's full-chain solution for merchants includes "platform policies + traffic support + growth strategies," which has become a key engine for driving business growth [2] Group 2: Marketing and Consumer Engagement - During the 2025 Spring Festival, JD's service provided supply guarantees in 29 cities, offering freight subsidies and promotional support to merchants, thus creating new growth points [2] - The platform's marketing strategies have led to a significant increase in order volume, with a 4-fold year-on-year growth during the 618 shopping festival and a 6-fold increase in new users [2] - JD's targeted marketing campaigns, such as the collaboration with Kexinrou for allergy medications, resulted in a 20-fold increase in GMV and a nearly 16-fold increase in new customers [5] Group 3: Brand Value and Market Positioning - JD's service is helping pharmaceutical companies transition from merely selling products to delivering health value, supported by a nationwide supply network and rapid delivery capabilities [4] - The platform's insights into consumer behavior and category trends assist pharmaceutical companies in optimizing product strategies [4] - The introduction of a merchant evaluation system allows for quick identification of operational weaknesses, providing incentives for high-quality merchants [3] Group 4: Future Outlook and Technological Integration - The O2O pharmaceutical market is entering a critical phase of "value co-creation," with JD's focus on empowering partners through digital capabilities [6][7] - The "京医千询" medical model and AI-driven tools are set to enhance intelligent product selection and precise marketing for merchants [7] - JD plans to further reduce operating costs and consumer barriers while providing incentives for high-growth merchants, aiming for sustainable growth in the instant retail sector [7]